Semler Scientific (NASDAQ:SMLR) Releases Earnings Results, Beats Estimates By $0.08 EPS

Semler Scientific (NASDAQ:SMLRGet Free Report) posted its earnings results on Monday. The company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.56 by $0.08, Yahoo Finance reports. The firm had revenue of $14.47 million for the quarter. Semler Scientific had a net margin of 32.92% and a return on equity of 30.36%.

Semler Scientific Trading Up 4.6 %

Shares of SMLR traded up $1.20 during mid-day trading on Tuesday, hitting $27.52. 568,647 shares of the company’s stock were exchanged, compared to its average volume of 204,204. The firm has a market capitalization of $194.57 million, a P/E ratio of 9.86 and a beta of 1.00. Semler Scientific has a fifty-two week low of $20.88 and a fifty-two week high of $53.38. The business’s 50 day moving average is $33.41 and its two-hundred day moving average is $34.00.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital raised shares of Semler Scientific to a “strong-buy” rating in a research report on Wednesday, May 8th.

Get Our Latest Stock Report on Semler Scientific

Semler Scientific Company Profile

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Featured Articles

Earnings History for Semler Scientific (NASDAQ:SMLR)

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.